1. Home
  2. USIO vs INCR Comparison

USIO vs INCR Comparison

Compare USIO & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Usio Inc.

USIO

Usio Inc.

HOLD

Current Price

$1.96

Market Cap

58.8M

Sector

Finance

ML Signal

HOLD

Logo Intercure Ltd.

INCR

Intercure Ltd.

HOLD

Current Price

$0.92

Market Cap

47.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USIO
INCR
Founded
1998
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.8M
47.4M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
USIO
INCR
Price
$1.96
$0.92
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
160.8K
18.4K
Earning Date
05-13-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$28,200,535.00
N/A
Revenue This Year
$12.15
$69.54
Revenue Next Year
$8.57
$41.75
P/E Ratio
N/A
N/A
Revenue Growth
12.69
N/A
52 Week Low
$1.03
$0.68
52 Week High
$2.62
$1.77

Technical Indicators

Market Signals
Indicator
USIO
INCR
Relative Strength Index (RSI) 45.67 44.79
Support Level $1.36 $0.85
Resistance Level $2.61 $0.98
Average True Range (ATR) 0.18 0.05
MACD -0.06 -0.01
Stochastic Oscillator 14.86 37.47

Price Performance

Historical Comparison
USIO
INCR

About USIO Usio Inc.

Usio Inc is a cloud-based Fintech payment processor. The company serves multiple industry verticals with technology that facilitates payment acceptance and funds disbursement in a single, full-stack ecosystem. It provides payment acceptance through multiple payment methods, including payment facilitation, prepaid card, and electronic billing products and services to businesses, merchants, and consumers. The company's reportable operating segments are Output Solutions and Merchant Services, and these segments.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: